HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shin-Ichi Tashiro Selected Research

Fibrosarcoma

9/2017Collagen gel protects L929 cells from TNFα-induced death by activating NF-κB.
1/2016Gelatin promotes murine fibrosarcoma L929 cell detachment and protects the cells from TNFα-induced cytotoxicity.
2/2015Type I collagen gel protects murine fibrosarcoma L929 cells from TNFα-induced cell death.
11/2013Negatively-regulated necroptosis by autophagy required caspase-6 activation in TNFα-treated murine fibrosarcoma L929 cells.
9/2013mTOR inactivation by ROS-JNK-p53 pathway plays an essential role in psedolaric acid B induced autophagy-dependent senescence in murine fibrosarcoma L929 cells.
12/2012RIP1-mediated mitochondrial dysfunction and ROS production contributed to tumor necrosis factor alpha-induced L929 cell necroptosis and autophagy.
8/2012Oridonin induces apoptosis and autophagy in murine fibrosarcoma L929 cells partly via NO-ERK-p53 positive-feedback loop signaling pathway.
5/2012Pseudolaric acid B induces mitotic catastrophe followed by apoptotic cell death in murine fibrosarcoma L929 cells.
1/2011Silibinin activated ROS-p38-NF-κB positive feedback and induced autophagic death in human fibrosarcoma HT1080 cells.
3/2009Autophagy inhibits reactive oxygen species-mediated apoptosis via activating p38-nuclear factor-kappa B survival pathways in oridonin-treated murine fibrosarcoma L929 cells.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shin-Ichi Tashiro Research Topics

Disease

15Fibrosarcoma
09/2017 - 03/2004
13Melanoma (Melanoma, Malignant)
01/2017 - 11/2003
11Neoplasms (Cancer)
09/2018 - 01/2004
5Necrosis
09/2008 - 11/2003
5Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2005 - 01/2004
4Inflammation (Inflammations)
12/2018 - 01/2016
4Breast Neoplasms (Breast Cancer)
09/2018 - 01/2010
4Lymphoma (Lymphomas)
02/2013 - 03/2005
3Lung Neoplasms (Lung Cancer)
10/2017 - 11/2013
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2012 - 01/2008
3Carcinoma (Carcinomatosis)
01/2012 - 12/2007
2Fibrosis (Cirrhosis)
01/2019 - 07/2018
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2018 - 01/2018
2Liver Diseases (Liver Disease)
10/2017 - 07/2016
2Laryngeal Neoplasms (Laryngeal Cancer)
12/2015 - 08/2010
2Mitochondrial Diseases (Mitochondrial Disease)
12/2012 - 11/2012
2Adenocarcinoma
06/2004 - 03/2004
1Type 2 Diabetes Mellitus (MODY)
06/2018
1Peritonitis
06/2018
1Alzheimer Disease (Alzheimer's Disease)
04/2018
1Memory Disorders (Memory Loss)
04/2017
1Neuroinflammatory Diseases
04/2017
1Ciliopathies
09/2016
1Neurodegenerative Diseases (Neurodegenerative Disease)
07/2016
1Tuberous Sclerosis (Bourneville's Disease)
09/2013
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2012
1Pheochromocytoma
07/2011
1Cognitive Dysfunction
07/2011
1Squamous Cell Carcinoma of Head and Neck
06/2010
1Insulin Resistance
12/2008
1Acute Monocytic Leukemia (Acute Monoblastic Leukemia)
03/2004

Drug/Important Bio-Agent (IBA)

18oridoninIBA
12/2015 - 06/2004
12Silybin (Lagosa)IBA
06/2018 - 01/2010
8CaspasesIBA
11/2013 - 11/2003
7DiterpenesIBA
10/2017 - 06/2004
6Reactive Oxygen Species (Oxygen Radicals)IBA
02/2013 - 09/2008
5Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2012 - 01/2008
4Biological ProductsIBA
01/2018 - 02/2004
4pseudolaric acid BIBA
10/2017 - 01/2005
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2016 - 12/2005
4evodiamineIBA
01/2008 - 11/2003
3CollagenIBA
01/2019 - 01/2018
3AcidsIBA
10/2017 - 09/2013
3FlavonoidsIBA
10/2017 - 07/2016
3benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA
11/2013 - 12/2005
3Proteins (Proteins, Gene)FDA Link
09/2013 - 05/2012
3SilymarinIBA
11/2012 - 10/2005
3norcantharidinIBA
01/2012 - 08/2004
2Pattern Recognition ReceptorsIBA
12/2018 - 01/2018
2RNA (Ribonucleic Acid)IBA
12/2018 - 01/2018
2Toll-Like Receptor 3IBA
12/2018 - 01/2018
2GelatinIBA
01/2018 - 01/2016
2Collagen Type I (Type I Collagen)IBA
09/2017 - 02/2015
2Amyloid (Amyloid Fibrils)IBA
04/2017 - 07/2011
2Caspase 9IBA
12/2015 - 08/2004
2RTKI cpdIBA
11/2012 - 08/2010
2ErbB Receptors (EGF Receptor)IBA
11/2012 - 08/2010
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
09/2008 - 12/2005
1CateninsIBA
01/2019
1artenimol (dihydroartemisinin)IBA
09/2018
1JNK Mitogen-Activated Protein KinasesIBA
09/2018
1Transforming Growth Factors (Transforming Growth Factor)IBA
07/2018
1Insulin (Novolin)FDA Link
06/2018
1Glucose (Dextrose)FDA LinkGeneric
10/2017
1timosaponin AIIIIBA
01/2017
1Pharmaceutical PreparationsIBA
07/2016
1Antineoplastic Agents (Antineoplastics)IBA
12/2015
1CytokinesIBA
02/2015
1Caspase 6IBA
11/2013
1necrostatin-1IBA
12/2012
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
12/2012
1Cytochromes c (Cytochrome c)IBA
12/2012
13-methyladenineIBA
12/2012
1AntioxidantsIBA
11/2012
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2012
1Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric
07/2011
1TyrphostinsIBA
08/2010
1Superoxides (Superoxide)IBA
01/2010
1Estradiol (Delestrogen)FDA LinkGeneric
12/2008
1Estrogens (Estrogen)FDA Link
12/2008
1Testosterone (Sustanon)FDA Link
12/2008
1LipidsIBA
12/2008
1Insulin-Like PeptidesIBA
07/2008
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2008
1NF-kappa B (NF-kB)IBA
01/2008
1Sepharose (Agarose)IBA
12/2005
1Caspase 3 (Caspase-3)IBA
08/2004
1ponicidinIBA
06/2004
1Ethanol (Ethyl Alcohol)IBA
06/2004
1rutecarpineIBA
03/2004
1AlkaloidsIBA
03/2004
1shikoninIBA
02/2004
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2004

Therapy/Procedure

1Therapeutics
08/2010
1Aftercare (After-Treatment)
09/2008